Tapewire

NYSE · USD

PFE

PFIZER INC

Export transactions ↓
Tapewire entity
2863
SEC CIK
0000078003
Parsed reports
4,941

Last 12 months

Inside the activity.

3 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202631
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 20, 2018 Filed Jul 24, 2018 17:09 UTC
SUSMAN SALLYExecutive Vice President
SaleCommon Stock 2,780 $37.26 $103,582.80
Disclosure

SEC source: 0001225208-18-011922 · doc4.xml · nonDerivative · entry 13

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,480

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2018.

Read SEC document
July 20, 2018 Filed Jul 24, 2018 17:09 UTC
SUSMAN SALLYExecutive Vice President
SaleCommon Stock 2,408 $37.16 $89,481.28
Disclosure

SEC source: 0001225208-18-011922 · doc4.xml · nonDerivative · entry 12

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,260

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2018.

Read SEC document
July 20, 2018 Filed Jul 24, 2018 17:09 UTC
SUSMAN SALLYExecutive Vice President
SaleCommon Stock 2,288 $37.19 $85,090.72
Disclosure

SEC source: 0001225208-18-011922 · doc4.xml · nonDerivative · entry 11

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,668

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2018.

Read SEC document
July 20, 2018 Filed Jul 24, 2018 17:09 UTC
SUSMAN SALLYExecutive Vice President
SaleCommon Stock 1,700 $37.23 $63,291.00
Disclosure

SEC source: 0001225208-18-011922 · doc4.xml · nonDerivative · entry 10

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,956

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2018.

Read SEC document
July 20, 2018 Filed Jul 24, 2018 17:09 UTC
SUSMAN SALLYExecutive Vice President
SaleCommon Stock 1,565 $37.18 $58,186.70
Disclosure

SEC source: 0001225208-18-011922 · doc4.xml · nonDerivative · entry 9

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,656

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2018.

Read SEC document
July 20, 2018 Filed Jul 24, 2018 17:09 UTC
SUSMAN SALLYExecutive Vice President
SaleCommon Stock 1,300 $37.28 $48,464.00
Disclosure

SEC source: 0001225208-18-011922 · doc4.xml · nonDerivative · entry 8

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,221

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2018.

Read SEC document
July 20, 2018 Filed Jul 24, 2018 17:09 UTC
SUSMAN SALLYExecutive Vice President
SaleCommon Stock 1,000 $37.27 $37,270.00
Disclosure

SEC source: 0001225208-18-011922 · doc4.xml · nonDerivative · entry 7

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,521

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2018.

Read SEC document
July 20, 2018 Filed Jul 24, 2018 17:09 UTC
SUSMAN SALLYExecutive Vice President
SaleCommon Stock 830 $37.30 $30,959.00
Disclosure

SEC source: 0001225208-18-011922 · doc4.xml · nonDerivative · entry 6

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,521

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2018.

Read SEC document
July 20, 2018 Filed Jul 24, 2018 17:09 UTC
SUSMAN SALLYExecutive Vice President
SaleCommon Stock 700 $37.24 $26,068.00
Disclosure

SEC source: 0001225208-18-011922 · doc4.xml · nonDerivative · entry 5

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,351

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2018.

Read SEC document
July 20, 2018 Filed Jul 24, 2018 17:09 UTC
SUSMAN SALLYExecutive Vice President
SaleCommon Stock 600 $37.29 $22,374.00
Disclosure

SEC source: 0001225208-18-011922 · doc4.xml · nonDerivative · entry 4

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,051

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2018.

Read SEC document
July 20, 2018 Filed Jul 24, 2018 17:09 UTC
SUSMAN SALLYExecutive Vice President
SaleCommon Stock 426 $37.14 $15,821.64
Disclosure

SEC source: 0001225208-18-011922 · doc4.xml · nonDerivative · entry 3

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,651

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2018.

Read SEC document
July 20, 2018 Filed Jul 24, 2018 17:09 UTC
SUSMAN SALLYExecutive Vice President
SaleCommon Stock 300 $37.13 $11,139.00
Disclosure

SEC source: 0001225208-18-011922 · doc4.xml · nonDerivative · entry 2

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,077

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2018.

Read SEC document
July 20, 2018 Filed Jul 24, 2018 17:09 UTC
SUSMAN SALLYExecutive Vice President
SaleCommon Stock 100 $37.15 $3,715.00
Disclosure

SEC source: 0001225208-18-011922 · doc4.xml · nonDerivative · entry 1

SUSMAN SALLY · CIK 0001263544 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,377

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 72,852 $37.35 $2,721,022.20
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 25

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 659,440

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 61,325 $37.34 $2,289,875.50
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 24

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 732,292

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 55,127 $37.36 $2,059,544.72
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 23

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 793,617

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 46,564 $37.37 $1,740,096.68
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 22

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 848,744

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 42,558 $37.40 $1,591,669.20
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 21

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 895,308

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 34,099 $37.30 $1,271,892.70
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 20

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 937,866

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 32,431 $37.33 $1,210,649.23
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 19

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 971,965

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 31,033 $37.39 $1,160,323.87
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 18

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,004,396

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 27,875 $37.38 $1,041,967.50
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 17

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,035,429

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 24,163 $37.32 $901,763.16
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 16

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,063,304

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 16,111 $37.31 $601,101.41
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 15

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,087,467

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 7,700 $37.41 $288,057.00
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 14

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,103,578

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 5,800 $37.50 $217,500.00
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 13

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,111,278

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 4,215 $37.42 $157,725.30
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 12

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,117,078

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 4,000 $37.47 $149,880.00
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 11

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,121,293

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 3,500 $37.49 $131,215.00
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 10

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,125,293

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 3,400 $37.48 $127,432.00
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 9

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,128,793

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 3,300 $37.43 $123,519.00
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 8

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,132,193

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 3,300 $37.46 $123,618.00
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 7

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,135,493

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 2,200 $37.51 $82,522.00
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 6

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,138,793

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 2,100 $37.45 $78,645.00
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 5

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,140,993

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 1,000 $37.53 $37,530.00
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 4

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,143,093

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 900 $37.52 $33,768.00
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 3

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,144,093

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 700 $37.54 $26,278.00
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 2

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,144,993

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 16, 2018 Filed Jul 17, 2018 20:59 UTC
READ IAN CDirector · Chairman & CEO
SaleCommon Stock 500 $37.44 $18,720.00
Disclosure

SEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 1

READ IAN C · CIK 0001372915 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,145,693

F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018.

Read SEC document
July 13, 2018 Filed Jul 17, 2018 21:01 UTC
BOURLA ALBERTDirector · Chief Operating Officer
GrantPhantom Stock Units SSP · Derivative 23 $37.53 $863.19
Disclosure

SEC source: 0001225208-18-011786 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,189

Underlying: Common Stock · 23 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
July 13, 2018 Filed Jul 17, 2018 21:01 UTC
JOHNSON RADY AExecutive Vice President
GrantPhantom Stock Units SSP · Derivative 4 $37.53 $150.12
Disclosure

SEC source: 0001225208-18-011787 · doc4.xml · derivative · entry 1

JOHNSON RADY A · CIK 0001594762 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,530

Underlying: Common Stock · 4 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
July 13, 2018 Filed Jul 17, 2018 21:01 UTC
ROGERS DAWNExecutive Vice President
GrantPhantom Stock Units SSP · Derivative 47 $37.53 $1,763.91
Disclosure

SEC source: 0001225208-18-011788 · doc4.xml · derivative · entry 1

ROGERS DAWN · CIK 0001742308 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,772

Underlying: Common Stock · 47 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
July 13, 2018 Filed Jul 17, 2018 21:01 UTC
YOUNG JOHN DGroup President
GrantPhantom Stock Units SSP · Derivative 11 $37.53 $412.83
Disclosure

SEC source: 0001225208-18-011789 · doc4.xml · derivative · entry 1

YOUNG JOHN D · CIK 0001551792 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,328

Underlying: Common Stock · 11 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
July 11, 2018 Filed Jul 13, 2018 14:01 UTC
BOURLA ALBERTDirector · Chief Operating Officer
GrantPhantom Stock Units SSP · Derivative 42 $37.21 $1,562.82
Disclosure

SEC source: 0001225208-18-011640 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,167

Underlying: Common Stock · 42 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
July 11, 2018 Filed Jul 13, 2018 14:01 UTC
JOHNSON RADY AExecutive Vice President
GrantPhantom Stock Units SSP · Derivative 18 $37.21 $669.78
Disclosure

SEC source: 0001225208-18-011641 · doc4.xml · derivative · entry 1

JOHNSON RADY A · CIK 0001594762 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,526

Underlying: Common Stock · 18 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
July 11, 2018 Filed Jul 13, 2018 14:01 UTC
ROGERS DAWNExecutive Vice President
GrantPhantom Stock Units SSP · Derivative 173 $37.21 $6,437.33
Disclosure

SEC source: 0001225208-18-011642 · doc4.xml · derivative · entry 1

ROGERS DAWN · CIK 0001742308 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,725

Underlying: Common Stock · 173 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
July 11, 2018 Filed Jul 13, 2018 14:01 UTC
YOUNG JOHN DGroup President
GrantPhantom Stock Units SSP · Derivative 37 $37.21 $1,376.77
Disclosure

SEC source: 0001225208-18-011643 · doc4.xml · derivative · entry 1

YOUNG JOHN D · CIK 0001551792 · Group President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,318

Underlying: Common Stock · 37 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
June 29, 2018 Filed Jul 2, 2018 21:37 UTC GrantPhantom Stock Units · Derivative 1,119.76 $36.28 $40,624.89
Disclosure

SEC source: 0001225208-18-011085 · doc4.xml · derivative · entry 1

Echevarria Joseph · CIK 0001633137 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,684.417

Underlying: Common Stock · 1,119.76 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
June 29, 2018 Filed Jul 2, 2018 21:37 UTC GrantPhantom Stock Units · Derivative 937.65 $36.28 $34,017.94
Disclosure

SEC source: 0001225208-18-011086 · doc4.xml · derivative · entry 1

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,098.971

Underlying: Common Stock · 937.65 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
June 29, 2018 Filed Jul 2, 2018 21:38 UTC GrantPhantom Stock Units · Derivative 1,183.75 $36.28 $42,946.45
Disclosure

SEC source: 0001225208-18-011087 · doc4.xml · derivative · entry 1

NARAYEN SHANTANU · CIK 0001224154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,009.505

Underlying: Common Stock · 1,183.75 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
June 29, 2018 Filed Jul 2, 2018 21:38 UTC GrantPhantom Stock Units · Derivative 1,144.37 $36.28 $41,517.74
Disclosure

SEC source: 0001225208-18-011088 · doc4.xml · derivative · entry 1

SMITH JAMES C · CIK 0001611777 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,967.373

Underlying: Common Stock · 1,144.37 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.